Press/Media

Journal Publications and Media Stories Featuring Neovasc and Our Work in Tissue Supply, Refractory Angina Treatment, and Transcatheter Mitral Valve Replacement (TMVR)

 

LHSC first in Ontario to implant Canadian made mitral valve device

The cardiac team at London Health Sciences Centre (LHSC) is the first in Ontario to implant the Canadian made Neovasc Tiara transcatheter device to correct a leaky mitral valve.


Cardiology in Review

Narrowing of the coronary sinus, a device based therapy for angina pectoris


Danny Dvir EuroIntervention

Transapical mitral valve implantation after unclipping of a MitraClip: a glimpse into the future and treatment considerations in mitral regurgitation


 

Reducer UMCU Experience

Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience


 

The New England Journal of Medicine

Neovasc Reducer: Positive results from the COSIRA Clinical Study


 

header-newspaper-cn-70px

 

 

 

Data confirm the Neovasc reducer improves functional capabilities in refractory angina patients 

 


 

newswire_logo

 

 

 

Neovasc soars on 1st-in-human implant of Tiara transcatheter mitral valve

 


 

eurointervention

 

 

 

Transcatheter treatment for refractory angina with the coronary sinus Reducer

 


 

logo-tctmd-home

 

 

 

 


 

JACC

 

Trans Apical Mitral Implantation (TAMI) of the Tiara TM Bio-prosthesis: Pre-Clinical Results

 


 

JACC

 

Tiara: A Novel Catheter-Based Mitral Valve Bioprosthesis
Initial Experiments and Short-Term Pre-Clinical Results

 


 

JACC

 

Study published on the Reducer stent for the Treatment of Chronic Refractory Angina Pectoris: Abstract   |  Full study